# A Prospective Real World Study of Rimegepant in the Treatment of Migraine

> **NCT05709106** · — · COMPLETED · sponsor: **Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine** · enrollment: 173 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Rimegepant 75 MG

## Key facts

- **NCT ID:** NCT05709106
- **Lead sponsor:** Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-11
- **Primary completion:** 2024-10-06
- **Final completion:** 2025-04-09
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05709106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05709106, "A Prospective Real World Study of Rimegepant in the Treatment of Migraine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05709106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*